idarubicin has been researched along with Bone Cancer in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
López Carrizosa, MC; Ortiz Cruz, E; Rodríguez Pérez, A; Samper Ots, PM; Villalón Blanco, L | 1 |
Anderson, LD; Collins, RH; Kirk, A; Levitt, D; Naina, HV; Scaglioni, PP; Vusirikala, M | 1 |
Corona, G; Crivellari, D; Lestuzzi, C; Lombardi, D; Lucenti, A; Magri, MD; Massacesi, C; Sorio, R; Talamini, R; Toffoli, G; Veronesi, A | 1 |
Kneisl, JS; Lipford, EH; Woodard, WL | 1 |
Casak, S; Chantada, GL; Fandiño, A; Mato, G | 1 |
Brandi, M; De Lena, M; Logroscino, A; Lorusso, V; Maiello, E; Paradiso, A | 1 |
Bozzi, D; Brandi, M; Calabrese, P; De Lena, M; Romito, S | 1 |
2 trial(s) available for idarubicin and Bone Cancer
Article | Year |
---|---|
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Idarubicin; Liver Neoplasms; Lung Neoplasms; Soft Tissue Neoplasms | 2006 |
Phase II window of idarubicin in children with extraocular retinoblastoma.
Topics: Antibiotics, Antineoplastic; Bone Marrow Neoplasms; Bone Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infant; Lymphatic Metastasis; Male; Neoplasms, Multiple Primary; Orbital Neoplasms; Retinoblastoma; Treatment Outcome | 1999 |
5 other study(ies) available for idarubicin and Bone Cancer
Article | Year |
---|---|
Granulocytic sarcoma of the right humerus in a non-leukaemia patient.
Topics: Aged; Antineoplastic Agents; Arthroplasty, Replacement; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Female; Fractures, Spontaneous; Humans; Humerus; Idarubicin; Osteolysis; Remission Induction; Sarcoma, Myeloid; Shoulder Fractures | 2008 |
Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.
Topics: Adult; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Bone Marrow; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Oxides; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma, Myeloid; Soft Tissue Neoplasms; Tetrahydronaphthalenes; Tretinoin | 2011 |
Isolated granulocytic sarcoma of the humerus.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Cytarabine; Diagnosis, Differential; Fatal Outcome; Humans; Humerus; Idarubicin; Leukemia, Myeloid; Magnetic Resonance Imaging; Male; Pain; Radiotherapy, Adjuvant; Tomography, X-Ray Computed | 1999 |
Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.
Topics: Administration, Oral; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Remission Induction; Soft Tissue Neoplasms | 1988 |
4-Demethoxydaunorubicin administered orally in advanced breast cancer. A phase II study.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Aged; Bone Marrow Diseases; Bone Neoplasms; Breast Neoplasms; Daunorubicin; Female; Humans; Idarubicin; Middle Aged; Nausea; Soft Tissue Neoplasms; Stomach Ulcer; Vomiting | 1988 |